OPKO Acquires ModeX Therapeutics
Our Vision
At OPKO Health, the entrepreneurial acumen of our founder and CEO, Dr. Phillip Frost, has led to the development of a diverse healthcare company flexible enough to adapt to evolving patient needs. We are proud of our first in class products, Rayaldee® (calcifediol), and the 4Kscore® test, as well as our diagnostics division, BioReference Laboratories and GeneDx. In addition to our clinical products and diagnostics, we have a robust research and development pipeline and a variety of biomedical and pharmaceutical business solutions.
Our History
Since our founding in 2007, OPKO has grown into a global healthcare company, with over 5,500 employees spanning nine countries, through organic growth and complementary acquisitions.
View Our HistoryWe Want To Hear From You
If you have questions about our company and would like to know more, we would love to hear from you.
Contact Us
OPKO Leadership Team (from left to right):
Adam Logal, Senior Vice-President and Chief Financial Officer
Jane H. Hsiao Ph.D., M.B.A., Chief Technical Officer and Vice Chairman
Phillip Frost M.D., OPKO Health CEO & Chairman
Steven D. Rubin, Executive Vice-President, Administration
Our Leadership
OPKO Health's senior management has worked together for many years, both at OPKO and at other companies, and has a strong record of successfully building innovative healthcare companies and increasing shareholder value.
Management Team Board of Directors